Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideELVElevance Health
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | ELV | TMO |
|---|
| Close | 420.07 | 697.00 |
| Market Cap | $90.8B | $258B |
| 1M | +8.04% | +3.25% |
| P/E (TTM) | 17.9 | 36.4 |
| Forward P/E | 14.0 | 24.6 |
| P/E 5-Yr Percentile | 66 | 78 |
| P/S | 0.5 | 5.4 |
| P/B | 2.1 | 4.7 |
| Dividend Yield | 1.24% | 0.29% |
| Latest Quarter Revenue | $51.4B | $12.1B |
| Revenue YoY | +1.4% | +9.1% |
| Gross Margin | 89.0% | — |
| Latest Quarter EPS | 6.27 | 4.64 |
| Avg Post-Earnings Move | ±3.8% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.03% | 1.82% |
| 90-Day Net Insider Buying | −$4.7M | −$40.3M |
ELV · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
